GLP-1 Receptor Agonists Do Not Cause Tumor Growth in Patients with Papillary Thyroid Carcinoma Undergoing Active Surveillance

Abstract

Get full access to this article

View all access options for this article.

References

Bethel

, Patel

, Merrill

, et al. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: A meta-analysis. Lancet Diabetes Endocrinol, 2018; 6(2):105-113; doi: 10.1016/S2213-8587(17)30412-6.

Madsen

, Knauf

, Gotfredsen

, et al. GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology, 2012; 153(3):1538-1547; doi: 10.1210/en.2011-1864.

Hegedüs

, Sherman

, Tuttle

, et al. No evidence of increase in calcitonin concentrations or development of C-cell malignancy in response to liraglutide for up to 5 years in the LEADER trial. Diabetes Care, 2018; 41(3):620-622; doi: 10.2337/dc17-1956.

Bethel

, Patel

, Thompson

, et al. Changes in serum calcitonin concentrations, incidence of medullary thyroid carcinoma, and impact of routine calcitonin concentration monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes Care, 2019; 42(6):1075-1080; doi: 10.2337/dc18-2028.

, Zhang

, et al. Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer. Onco Targets Ther, 2017; 10:5621-5631; doi: 10.2147/OTT.S150701.

Patrizio

, Newman

, Tuttle

, et al. Effect of GLP-1 receptor agonists on patients with thyroid carcinomas undergoing active surveillance. J Endocr Soc. 2025; 10(1):bvaf182; doi: 10.1210/jendso/bvaf182.

Tuttle

, Fagin

, Minkowitz

, et al. Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance. JAMA Otolaryngol Head Neck Surg, 2017; 143(10):1015-1020; doi: 10.1001/jamaoto.2017.1442.

Brito

, Herrin

, Swarna

, et al. GLP-1RA use and thyroid cancer risk. JAMA Otolaryngol Head Neck Surg, 2025; 151(3):243-252; doi: 10.1001/jamaoto.2024.4852.

American Diabetes Association. The burden of diabetes in North Carolina. https://diabetes.org/sites/default/files/2024-03/adv_2024_state_fact_north_carolina.pdf.

10.

Centers for Disease Control, National Center for Health Statistics. Stats of the states: Diabetes mortality. https://www.cdc.gov/nchs/state-stats/deaths/diabetes.html.

11.

Renehan

, Tyson

, Egger

, et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet, 2008; 371(9612):569-578; doi: 10.1016/S0140-6736(08)60269-X.

12.

Zhao

, Zhang

, Yang

, et al. High prevalence of thyroid carcinoma in patients with insulin resistance: A meta-analysis of case-control studies. Aging (Albany NY), 2021; 13(18):22232-22241; doi: 10.18632/aging.203529.